Cognitive symptoms are common among individuals living with brain tumours and can significantly affect daily life and well-being. This webinar […]
Dr. Teresa Purzner earned her MD in 2009 and completed four years of neurosurgical residency in Toronto before pursuing a PhD in developmental neurobiology at Stanford University. There, she combined mass spectrometry with developmental biology to identify novel therapeutic targets for pediatric brain tumours, leading to the discovery of a new drug target in medulloblastoma.
Dr. Yuan obtained a PhD degree in Statistics from the University of Waterloo in 2008 and joined the School of Public Health at the University of Alberta in 2011. Her research program focused on developing and applying biostatistical methods in cancer related to population health and biomedical research.
This heartfelt session explores the often-unspoken grief experienced by caregivers as they accompany a loved one through illness, decline, and death. From anticipatory grief to the quiet sorrow that lingers beyond loss, caregivers carry a unique emotional burden that can be deeply isolating.
This webinar explains the key biological factors that make glioblastoma highly treatment-resistant, including cell-death pathways, tumour heterogeneity and the influence of brain location.
This presentation will focus on current and emerging uses of focused ultrasound for brain disease, with a specific focus on the potential treatment of neuro-oncologic disease.